Gene Symbol | Gene ID | Gene Info |
---|---|---|
Irf4
|
ENSMUSG00000021356.3 | interferon regulatory factor 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_30751536_30751687 | Irf4 | 2304 | 0.300338 | -0.06 | 6.4e-01 | Click! |
chr13_30748912_30751060 | Irf4 | 679 | 0.705119 | 0.00 | 1.0e+00 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_9573836_9576858 | 7.91 |
Osr1 |
odd-skipped related transcription factor 1 |
906 |
0.56 |
chr18_65085107_65085852 | 6.22 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
2425 |
0.36 |
chr16_34921565_34922483 | 6.15 |
Mylk |
myosin, light polypeptide kinase |
8318 |
0.19 |
chr14_101841178_101841822 | 6.00 |
Lmo7 |
LIM domain only 7 |
681 |
0.79 |
chr10_81128980_81129986 | 5.89 |
Map2k2 |
mitogen-activated protein kinase kinase 2 |
868 |
0.33 |
chr19_43916774_43917584 | 5.84 |
Gm50217 |
predicted gene, 50217 |
3294 |
0.17 |
chr13_4059546_4060650 | 5.52 |
Akr1c14 |
aldo-keto reductase family 1, member C14 |
507 |
0.71 |
chr12_34713492_34714861 | 5.40 |
Gm47357 |
predicted gene, 47357 |
85538 |
0.09 |
chr3_38202158_38202473 | 5.39 |
5430434I15Rik |
RIKEN cDNA 5430434I15 gene |
5804 |
0.21 |
chr6_31125380_31126701 | 5.38 |
5330406M23Rik |
RIKEN cDNA 5330406M23 gene |
15120 |
0.11 |
chr5_119669544_119672401 | 5.36 |
Tbx3 |
T-box 3 |
46 |
0.85 |
chr18_26015324_26015733 | 5.33 |
Gm33228 |
predicted gene, 33228 |
3225 |
0.39 |
chr7_80386817_80388333 | 5.15 |
Fes |
feline sarcoma oncogene |
156 |
0.91 |
chr19_5842574_5845856 | 5.15 |
Neat1 |
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
1044 |
0.25 |
chr1_77213373_77213909 | 5.05 |
Gm38265 |
predicted gene, 38265 |
66649 |
0.12 |
chr7_31054545_31055836 | 5.03 |
Fxyd1 |
FXYD domain-containing ion transport regulator 1 |
219 |
0.84 |
chr9_79976568_79977294 | 5.01 |
Filip1 |
filamin A interacting protein 1 |
728 |
0.66 |
chr18_65392658_65392927 | 4.95 |
Alpk2 |
alpha-kinase 2 |
1102 |
0.35 |
chr4_86875543_86876182 | 4.92 |
Acer2 |
alkaline ceramidase 2 |
1448 |
0.44 |
chr1_13293396_13293901 | 4.90 |
Gm38223 |
predicted gene, 38223 |
3142 |
0.16 |
chr8_36951282_36952693 | 4.83 |
Dlc1 |
deleted in liver cancer 1 |
370 |
0.88 |
chr15_76118017_76119354 | 4.80 |
Eppk1 |
epiplakin 1 |
1510 |
0.2 |
chr5_72796212_72796844 | 4.76 |
Tec |
tec protein tyrosine kinase |
10508 |
0.15 |
chr6_34598108_34599085 | 4.74 |
Cald1 |
caldesmon 1 |
24 |
0.98 |
chr7_4163531_4164895 | 4.72 |
Cdc42ep5 |
CDC42 effector protein (Rho GTPase binding) 5 |
229 |
0.84 |
chr4_11146992_11147797 | 4.68 |
Gm11830 |
predicted gene 11830 |
2684 |
0.17 |
chr9_105520039_105521535 | 4.63 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr13_114584421_114585156 | 4.62 |
Gm25950 |
predicted gene, 25950 |
4293 |
0.22 |
chr14_101842332_101842898 | 4.62 |
Lmo7 |
LIM domain only 7 |
1796 |
0.46 |
chr14_36918744_36919600 | 4.60 |
Ccser2 |
coiled-coil serine rich 2 |
161 |
0.97 |
chr9_111055888_111057545 | 4.59 |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
530 |
0.62 |
chr14_63241333_63241857 | 4.56 |
Gata4 |
GATA binding protein 4 |
3653 |
0.22 |
chr2_60939895_60940920 | 4.49 |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
22785 |
0.21 |
chr3_138064815_138065971 | 4.42 |
1110002E22Rik |
RIKEN cDNA 1110002E22 gene |
341 |
0.81 |
chr3_142619966_142621017 | 4.39 |
Gbp2 |
guanylate binding protein 2 |
111 |
0.95 |
chr2_105125289_105128976 | 4.37 |
Wt1 |
Wilms tumor 1 homolog |
78 |
0.91 |
chr7_142472156_142472970 | 4.35 |
Lsp1 |
lymphocyte specific 1 |
412 |
0.73 |
chr9_86631295_86631516 | 4.34 |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
12668 |
0.14 |
chr15_36879634_36879837 | 4.32 |
Gm10384 |
predicted gene 10384 |
81 |
0.97 |
chr1_118981436_118983032 | 4.25 |
Gli2 |
GLI-Kruppel family member GLI2 |
354 |
0.9 |
chr1_51288641_51290950 | 4.15 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr4_82065471_82066607 | 4.15 |
Gm5860 |
predicted gene 5860 |
82 |
0.6 |
chr8_22506948_22507557 | 4.15 |
Slc20a2 |
solute carrier family 20, member 2 |
1026 |
0.46 |
chr2_152626740_152627949 | 4.05 |
Rem1 |
rad and gem related GTP binding protein 1 |
391 |
0.68 |
chr3_27839708_27840308 | 4.04 |
Gm26040 |
predicted gene, 26040 |
28105 |
0.2 |
chr10_95394739_95395379 | 4.02 |
Socs2 |
suppressor of cytokine signaling 2 |
2092 |
0.23 |
chr6_108306267_108306822 | 4.01 |
Itpr1 |
inositol 1,4,5-trisphosphate receptor 1 |
49710 |
0.16 |
chr15_81044705_81045458 | 4.01 |
Mrtfa |
myocardin related transcription factor A |
465 |
0.76 |
chr2_114054589_114054921 | 4.00 |
C130080G10Rik |
RIKEN cDNA C130080G10 gene |
359 |
0.79 |
chr18_5603232_5604403 | 3.99 |
Zeb1 |
zinc finger E-box binding homeobox 1 |
73 |
0.96 |
chr3_152261831_152262449 | 3.95 |
Nexn |
nexilin |
390 |
0.79 |
chr16_23610624_23611298 | 3.91 |
Rtp4 |
receptor transporter protein 4 |
1036 |
0.59 |
chr14_21590027_21590511 | 3.85 |
Kat6b |
K(lysine) acetyltransferase 6B |
32273 |
0.19 |
chr5_86071761_86072070 | 3.85 |
Stap1 |
signal transducing adaptor family member 1 |
103 |
0.96 |
chr7_75586786_75587711 | 3.81 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
22791 |
0.17 |
chr15_94045386_94045586 | 3.78 |
Gm30564 |
predicted gene, 30564 |
80778 |
0.1 |
chr6_129180573_129181444 | 3.76 |
Clec2d |
C-type lectin domain family 2, member d |
393 |
0.77 |
chr19_20389423_20390852 | 3.75 |
Anxa1 |
annexin A1 |
514 |
0.81 |
chr14_79515651_79516545 | 3.70 |
Elf1 |
E74-like factor 1 |
400 |
0.83 |
chr17_81737002_81738450 | 3.67 |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
651 |
0.81 |
chr7_142660049_142661342 | 3.67 |
Igf2 |
insulin-like growth factor 2 |
510 |
0.56 |
chr13_24965703_24966284 | 3.62 |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
3366 |
0.18 |
chr19_32209821_32211372 | 3.59 |
Sgms1 |
sphingomyelin synthase 1 |
417 |
0.79 |
chr11_5802324_5803834 | 3.58 |
Pgam2 |
phosphoglycerate mutase 2 |
654 |
0.56 |
chr18_42052289_42053151 | 3.57 |
Sh3rf2 |
SH3 domain containing ring finger 2 |
947 |
0.61 |
chr1_58715750_58716759 | 3.57 |
Cflar |
CASP8 and FADD-like apoptosis regulator |
2368 |
0.2 |
chr1_40465628_40466339 | 3.55 |
Il18r1 |
interleukin 18 receptor 1 |
13 |
0.98 |
chr9_114730432_114730583 | 3.54 |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
609 |
0.7 |
chr2_69135753_69136848 | 3.54 |
Nostrin |
nitric oxide synthase trafficker |
500 |
0.81 |
chr17_80933683_80933890 | 3.54 |
Gm9386 |
predicted pseudogene 9386 |
4928 |
0.22 |
chr16_76679845_76680911 | 3.50 |
Gm45029 |
predicted gene 45029 |
135 |
0.97 |
chr2_118113734_118115108 | 3.49 |
Thbs1 |
thrombospondin 1 |
2545 |
0.2 |
chr17_44136051_44136319 | 3.48 |
Clic5 |
chloride intracellular channel 5 |
1417 |
0.48 |
chr17_23749018_23749914 | 3.47 |
9530082P21Rik |
RIKEN cDNA 9530082P21 gene |
129 |
0.87 |
chr8_105305363_105306677 | 3.46 |
Elmo3 |
engulfment and cell motility 3 |
325 |
0.64 |
chr14_99578342_99579719 | 3.46 |
Gm49225 |
predicted gene, 49225 |
40986 |
0.14 |
chr16_42152536_42153083 | 3.44 |
Lsamp |
limbic system-associated membrane protein |
8784 |
0.22 |
chr12_55490012_55490714 | 3.43 |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
1447 |
0.39 |
chr2_163395028_163395405 | 3.41 |
Jph2 |
junctophilin 2 |
2733 |
0.2 |
chr17_47597012_47597685 | 3.41 |
Ccnd3 |
cyclin D3 |
184 |
0.9 |
chr19_47168413_47169120 | 3.39 |
H1f11-ps |
H1.11 linker histone, pseudogene |
2368 |
0.16 |
chr12_34516988_34517182 | 3.38 |
Hdac9 |
histone deacetylase 9 |
11219 |
0.3 |
chr5_119830922_119832010 | 3.38 |
Gm43050 |
predicted gene 43050 |
325 |
0.82 |
chr18_41860653_41861741 | 3.38 |
Gm50410 |
predicted gene, 50410 |
13637 |
0.22 |
chr2_75776376_75777638 | 3.34 |
Gm13657 |
predicted gene 13657 |
181 |
0.93 |
chr15_40354651_40354850 | 3.33 |
Gm41311 |
predicted gene, 41311 |
11490 |
0.28 |
chr1_188866494_188866926 | 3.33 |
Ush2a |
usherin |
87034 |
0.09 |
chr3_148958783_148960002 | 3.32 |
Adgrl2 |
adhesion G protein-coupled receptor L2 |
4605 |
0.24 |
chr13_109211684_109213183 | 3.31 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
48221 |
0.19 |
chr2_76806846_76807416 | 3.30 |
Ttn |
titin |
19411 |
0.23 |
chr7_78913499_78914279 | 3.30 |
Isg20 |
interferon-stimulated protein |
92 |
0.95 |
chr15_5239360_5241096 | 3.29 |
Ptger4 |
prostaglandin E receptor 4 (subtype EP4) |
2482 |
0.22 |
chr5_66080287_66081072 | 3.28 |
Rbm47 |
RNA binding motif protein 47 |
305 |
0.84 |
chr18_11060506_11060780 | 3.27 |
Gata6 |
GATA binding protein 6 |
1596 |
0.43 |
chr9_120022870_120023448 | 3.26 |
Xirp1 |
xin actin-binding repeat containing 1 |
439 |
0.69 |
chr16_56477860_56479061 | 3.23 |
Abi3bp |
ABI gene family, member 3 (NESH) binding protein |
560 |
0.85 |
chr10_63886368_63887080 | 3.21 |
Gm10118 |
predicted gene 10118 |
40710 |
0.19 |
chr7_89405888_89406433 | 3.21 |
Fzd4 |
frizzled class receptor 4 |
1805 |
0.24 |
chr5_100413486_100413965 | 3.20 |
Sec31a |
Sec31 homolog A (S. cerevisiae) |
2441 |
0.22 |
chr16_14706735_14707615 | 3.19 |
Snai2 |
snail family zinc finger 2 |
1323 |
0.53 |
chr5_119673827_119675890 | 3.17 |
Tbx3 |
T-box 3 |
587 |
0.67 |
chr2_69672410_69673170 | 3.17 |
Klhl41 |
kelch-like 41 |
2670 |
0.21 |
chr18_4995747_4996610 | 3.17 |
Svil |
supervillin |
1242 |
0.62 |
chr16_43363328_43363642 | 3.16 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
21 |
0.7 |
chr5_125339293_125339748 | 3.15 |
Scarb1 |
scavenger receptor class B, member 1 |
488 |
0.73 |
chr6_94183402_94184029 | 3.15 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
99310 |
0.08 |
chr5_5261065_5262223 | 3.14 |
Cdk14 |
cyclin-dependent kinase 14 |
3665 |
0.25 |
chr6_24599678_24600100 | 3.13 |
Lmod2 |
leiomodin 2 (cardiac) |
2127 |
0.25 |
chr6_138143888_138144427 | 3.13 |
Mgst1 |
microsomal glutathione S-transferase 1 |
1303 |
0.58 |
chr3_145992694_145992897 | 3.12 |
Syde2 |
synapse defective 1, Rho GTPase, homolog 2 (C. elegans) |
876 |
0.58 |
chr14_99772626_99773392 | 3.11 |
Gm22970 |
predicted gene, 22970 |
799 |
0.67 |
chr13_119965491_119966496 | 3.10 |
Gm20784 |
predicted gene, 20784 |
3749 |
0.13 |
chr10_63459480_63459817 | 3.09 |
Ctnna3 |
catenin (cadherin associated protein), alpha 3 |
2138 |
0.3 |
chrX_19166017_19167833 | 3.09 |
Gm14636 |
predicted gene 14636 |
307 |
0.9 |
chr8_121082801_121085531 | 3.09 |
Foxf1 |
forkhead box F1 |
220 |
0.71 |
chr2_163694015_163694536 | 3.08 |
Pkig |
protein kinase inhibitor, gamma |
237 |
0.89 |
chr14_33362281_33363618 | 3.08 |
Arhgap22 |
Rho GTPase activating protein 22 |
573 |
0.71 |
chr19_8518372_8518525 | 3.07 |
Gm8189 |
predicted gene 8189 |
23350 |
0.14 |
chr10_102513522_102514467 | 3.06 |
Rassf9 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 |
1738 |
0.36 |
chr6_51173127_51174365 | 3.05 |
Mir148a |
microRNA 148a |
96164 |
0.07 |
chr10_68191368_68192460 | 3.04 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
55288 |
0.14 |
chr17_34197631_34198714 | 3.04 |
Psmb8 |
proteasome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7) |
198 |
0.82 |
chr3_41522196_41522994 | 3.03 |
2400006E01Rik |
RIKEN cDNA 2400006E01 gene |
622 |
0.65 |
chr14_60732734_60734396 | 3.03 |
Spata13 |
spermatogenesis associated 13 |
659 |
0.72 |
chr13_120096056_120097072 | 3.02 |
Gm21378 |
predicted gene, 21378 |
3768 |
0.15 |
chr15_99890238_99891314 | 3.01 |
Gm18890 |
predicted gene, 18890 |
7136 |
0.08 |
chr2_121441930_121443212 | 3.00 |
Ell3 |
elongation factor RNA polymerase II-like 3 |
30 |
0.93 |
chr15_78843437_78844143 | 2.99 |
Cdc42ep1 |
CDC42 effector protein (Rho GTPase binding) 1 |
1166 |
0.28 |
chr6_56899456_56900464 | 2.96 |
Nt5c3 |
5'-nucleotidase, cytosolic III |
1923 |
0.24 |
chr3_127123282_127124895 | 2.96 |
Ank2 |
ankyrin 2, brain |
774 |
0.59 |
chr2_39325776_39326109 | 2.95 |
Vmn2r-ps2 |
vomeronasal 2, receptor, pseudogene 2 |
51836 |
0.11 |
chr19_53794096_53794765 | 2.95 |
Rbm20 |
RNA binding motif protein 20 |
1122 |
0.48 |
chr5_92353176_92354033 | 2.95 |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
4715 |
0.11 |
chr7_123046454_123046709 | 2.94 |
Gm45847 |
predicted gene 45847 |
15087 |
0.14 |
chr11_101449130_101449504 | 2.93 |
Ifi35 |
interferon-induced protein 35 |
747 |
0.35 |
chr8_57318778_57318982 | 2.92 |
Hand2os1 |
Hand2, opposite strand 1 |
56 |
0.96 |
chr2_122149984_122150459 | 2.91 |
B2m |
beta-2 microglobulin |
2535 |
0.18 |
chr17_69395929_69396464 | 2.90 |
Gm49894 |
predicted gene, 49894 |
11988 |
0.14 |
chr10_23894263_23895356 | 2.90 |
Vnn1 |
vanin 1 |
45 |
0.96 |
chr9_48338929_48340200 | 2.90 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
1270 |
0.48 |
chr7_128248438_128248648 | 2.90 |
Tgfb1i1 |
transforming growth factor beta 1 induced transcript 1 |
367 |
0.71 |
chr12_37105849_37106478 | 2.89 |
Gm29007 |
predicted gene 29007 |
626 |
0.7 |
chr8_71788982_71789349 | 2.88 |
Gm35572 |
predicted gene, 35572 |
7843 |
0.12 |
chr14_101847539_101847690 | 2.86 |
Lmo7 |
LIM domain only 7 |
6795 |
0.28 |
chr1_131198772_131200130 | 2.86 |
Rassf5 |
Ras association (RalGDS/AF-6) domain family member 5 |
684 |
0.6 |
chr14_55193882_55194237 | 2.86 |
Gm46455 |
predicted gene, 46455 |
24350 |
0.1 |
chr15_59615158_59615846 | 2.86 |
Gm36677 |
predicted gene, 36677 |
3088 |
0.29 |
chr8_107560825_107561720 | 2.85 |
Wwp2 |
WW domain containing E3 ubiquitin protein ligase 2 |
9935 |
0.17 |
chr6_136873814_136874977 | 2.85 |
Mgp |
matrix Gla protein |
1386 |
0.26 |
chr6_24597837_24598262 | 2.85 |
Lmod2 |
leiomodin 2 (cardiac) |
287 |
0.88 |
chr19_27364312_27364550 | 2.85 |
Gm50113 |
predicted gene, 50113 |
1641 |
0.36 |
chr3_121890801_121891037 | 2.84 |
Gm42593 |
predicted gene 42593 |
28077 |
0.14 |
chr18_60646910_60648302 | 2.83 |
Synpo |
synaptopodin |
666 |
0.69 |
chr7_100494865_100496416 | 2.82 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
439 |
0.68 |
chr3_57293752_57294965 | 2.82 |
Tm4sf1 |
transmembrane 4 superfamily member 1 |
194 |
0.95 |
chr19_38042662_38044080 | 2.82 |
Myof |
myoferlin |
13 |
0.97 |
chr8_67948178_67948899 | 2.82 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
3341 |
0.28 |
chr9_21225354_21225714 | 2.81 |
Gm16754 |
predicted gene, 16754 |
131 |
0.92 |
chr9_120116040_120116439 | 2.81 |
Slc25a38 |
solute carrier family 25, member 38 |
1250 |
0.23 |
chr5_148360984_148361482 | 2.81 |
Slc7a1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
10313 |
0.23 |
chr19_20388210_20388662 | 2.80 |
Anxa1 |
annexin A1 |
2215 |
0.32 |
chr6_128889970_128890562 | 2.79 |
BC035044 |
cDNA sequence BC035044 |
858 |
0.36 |
chr3_50906219_50906818 | 2.79 |
Gm37843 |
predicted gene, 37843 |
15007 |
0.18 |
chr10_44447816_44448708 | 2.79 |
Prdm1 |
PR domain containing 1, with ZNF domain |
8948 |
0.19 |
chr2_158145151_158146425 | 2.78 |
Tgm2 |
transglutaminase 2, C polypeptide |
578 |
0.71 |
chr16_49792370_49792854 | 2.77 |
Gm15518 |
predicted gene 15518 |
6258 |
0.24 |
chr10_39908912_39909202 | 2.76 |
Gm8911 |
predicted gene 8911 |
2092 |
0.19 |
chr2_66783826_66785264 | 2.76 |
Scn7a |
sodium channel, voltage-gated, type VII, alpha |
369 |
0.91 |
chr9_40575537_40575975 | 2.75 |
Gm48277 |
predicted gene, 48277 |
14827 |
0.12 |
chr7_116197315_116198543 | 2.74 |
Plekha7 |
pleckstrin homology domain containing, family A member 7 |
632 |
0.75 |
chr10_21054842_21055897 | 2.74 |
Gm20149 |
predicted gene, 20149 |
6470 |
0.16 |
chr12_71886037_71886509 | 2.73 |
Daam1 |
dishevelled associated activator of morphogenesis 1 |
3457 |
0.28 |
chr8_61902204_61902661 | 2.73 |
Palld |
palladin, cytoskeletal associated protein |
237 |
0.92 |
chr12_117657998_117660727 | 2.72 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr19_53679305_53679727 | 2.72 |
Rbm20 |
RNA binding motif protein 20 |
2210 |
0.3 |
chr1_133418145_133418838 | 2.72 |
Sox13 |
SRY (sex determining region Y)-box 13 |
5886 |
0.2 |
chr13_77029776_77030116 | 2.72 |
Slf1 |
SMC5-SMC6 complex localization factor 1 |
17451 |
0.25 |
chr3_20152646_20152797 | 2.71 |
Gyg |
glycogenin |
2348 |
0.31 |
chr4_31823845_31825033 | 2.71 |
Map3k7 |
mitogen-activated protein kinase kinase kinase 7 |
139658 |
0.05 |
chr19_36734049_36734208 | 2.71 |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
2525 |
0.31 |
chr3_131334397_131335246 | 2.70 |
Sgms2 |
sphingomyelin synthase 2 |
10112 |
0.15 |
chr2_17460205_17460550 | 2.69 |
Nebl |
nebulette |
244 |
0.96 |
chr18_54900221_54900457 | 2.68 |
Zfp608 |
zinc finger protein 608 |
4777 |
0.23 |
chr15_66559688_66560010 | 2.67 |
Tmem71 |
transmembrane protein 71 |
1254 |
0.49 |
chr18_80169288_80170029 | 2.67 |
Gm7447 |
predicted gene 7447 |
6906 |
0.09 |
chr19_37436071_37437605 | 2.66 |
Hhex |
hematopoietically expressed homeobox |
99 |
0.94 |
chr17_46444584_46445824 | 2.66 |
Gm5093 |
predicted gene 5093 |
5107 |
0.11 |
chr9_49385382_49385733 | 2.65 |
Ankk1 |
ankyrin repeat and kinase domain containing 1 |
33879 |
0.17 |
chr16_59599420_59599980 | 2.65 |
Crybg3 |
beta-gamma crystallin domain containing 3 |
1279 |
0.47 |
chr8_47851685_47852685 | 2.65 |
Cldn22 |
claudin 22 |
27703 |
0.12 |
chr3_103736860_103738443 | 2.64 |
Olfml3 |
olfactomedin-like 3 |
317 |
0.76 |
chr6_48746767_48747146 | 2.63 |
Gimap5 |
GTPase, IMAP family member 5 |
657 |
0.42 |
chr8_115708807_115709461 | 2.63 |
Maf |
avian musculoaponeurotic fibrosarcoma oncogene homolog |
1340 |
0.49 |
chr1_58802310_58803113 | 2.63 |
Casp8 |
caspase 8 |
58 |
0.96 |
chr10_89708453_89708949 | 2.62 |
1500026H17Rik |
RIKEN cDNA 1500026H17 gene |
22330 |
0.14 |
chr10_42934964_42935541 | 2.61 |
Scml4 |
Scm polycomb group protein like 4 |
336 |
0.88 |
chr14_121365813_121366782 | 2.60 |
Stk24 |
serine/threonine kinase 24 |
6429 |
0.22 |
chr10_69928625_69928917 | 2.60 |
Ank3 |
ankyrin 3, epithelial |
2638 |
0.41 |
chr2_166030364_166031781 | 2.60 |
Ncoa3 |
nuclear receptor coactivator 3 |
16846 |
0.15 |
chr12_75853237_75854301 | 2.59 |
Syne2 |
spectrin repeat containing, nuclear envelope 2 |
1039 |
0.62 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.7 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
2.7 | 8.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
2.1 | 6.4 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
2.1 | 2.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
2.0 | 5.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.8 | 12.7 | GO:0072239 | metanephric glomerulus vasculature development(GO:0072239) |
1.8 | 5.4 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.8 | 8.9 | GO:0003175 | tricuspid valve development(GO:0003175) |
1.6 | 9.7 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.6 | 6.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.5 | 4.5 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
1.5 | 4.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.4 | 1.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.4 | 4.2 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
1.4 | 6.9 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
1.3 | 4.0 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
1.3 | 3.8 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.3 | 3.8 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
1.3 | 1.3 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.2 | 6.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.2 | 3.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.2 | 3.6 | GO:0061010 | gall bladder development(GO:0061010) |
1.2 | 2.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.1 | 3.4 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
1.1 | 2.2 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.1 | 5.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.0 | 3.1 | GO:0007525 | somatic muscle development(GO:0007525) |
1.0 | 3.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
1.0 | 4.0 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
1.0 | 3.0 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
1.0 | 3.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.0 | 1.0 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.9 | 2.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.9 | 5.6 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.9 | 2.8 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.9 | 2.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.9 | 2.7 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.9 | 2.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.9 | 2.7 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.9 | 1.7 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.9 | 2.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.9 | 7.7 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.9 | 0.9 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.9 | 3.4 | GO:0070432 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.8 | 1.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.8 | 3.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.8 | 3.3 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.8 | 4.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.8 | 1.6 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.8 | 2.4 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.7 | 4.5 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.7 | 2.2 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.7 | 2.9 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.7 | 2.9 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.7 | 1.5 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.7 | 2.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.7 | 2.9 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.7 | 1.5 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.7 | 0.7 | GO:0072125 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.7 | 2.2 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.7 | 2.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.7 | 4.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.7 | 1.4 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.7 | 3.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.7 | 2.1 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.7 | 2.0 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.6 | 1.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 1.3 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.6 | 0.6 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.6 | 3.8 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.6 | 0.6 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.6 | 0.6 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.6 | 2.5 | GO:0032264 | IMP salvage(GO:0032264) |
0.6 | 3.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.6 | 0.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.6 | 0.6 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.6 | 1.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.6 | 0.6 | GO:0070487 | monocyte aggregation(GO:0070487) |
0.6 | 1.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.6 | 1.2 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.6 | 4.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.6 | 0.6 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.6 | 2.3 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.6 | 2.8 | GO:0042737 | drug catabolic process(GO:0042737) |
0.6 | 1.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.6 | 1.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.6 | 2.8 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.6 | 2.2 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.6 | 1.7 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.5 | 1.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.5 | 1.6 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.5 | 2.1 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.5 | 0.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.5 | 3.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.5 | 2.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.5 | 3.6 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.5 | 0.5 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.5 | 1.5 | GO:0021564 | vagus nerve development(GO:0021564) |
0.5 | 1.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.5 | 2.0 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.5 | 2.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.5 | 2.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.5 | 1.0 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.5 | 1.5 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.5 | 2.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.5 | 1.5 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.5 | 1.5 | GO:0035483 | gastric emptying(GO:0035483) |
0.5 | 1.5 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.5 | 2.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.5 | 1.9 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.5 | 2.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.5 | 1.4 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.5 | 2.8 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.5 | 2.4 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.5 | 4.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.5 | 4.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.5 | 0.9 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.5 | 1.4 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.5 | 0.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.5 | 1.9 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.5 | 2.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.5 | 1.4 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.5 | 5.5 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
0.5 | 2.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.5 | 3.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.5 | 0.9 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.5 | 1.4 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.5 | 0.5 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.5 | 0.5 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.5 | 0.9 | GO:0032347 | negative regulation of aldosterone metabolic process(GO:0032345) regulation of aldosterone biosynthetic process(GO:0032347) negative regulation of aldosterone biosynthetic process(GO:0032348) regulation of cortisol biosynthetic process(GO:2000064) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.5 | 1.8 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.5 | 1.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.4 | 1.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.4 | 2.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.4 | 1.8 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.4 | 1.8 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.4 | 2.2 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.4 | 1.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.4 | 1.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 3.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.4 | 0.4 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.4 | 1.3 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.4 | 10.8 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.4 | 1.3 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.4 | 1.7 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.4 | 2.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 0.8 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.4 | 2.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.4 | 0.4 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.4 | 1.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.4 | 4.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 0.8 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.4 | 1.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.4 | 0.8 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.4 | 4.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.4 | 2.4 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.4 | 1.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.4 | 0.4 | GO:0052248 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.4 | 0.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.4 | 1.6 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.4 | 0.8 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.4 | 1.2 | GO:0008228 | opsonization(GO:0008228) |
0.4 | 1.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 1.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.4 | 0.8 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.4 | 0.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.4 | 0.8 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.4 | 1.2 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.4 | 0.4 | GO:0007494 | midgut development(GO:0007494) |
0.4 | 3.5 | GO:0090196 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.4 | 2.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.4 | 0.4 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.4 | 1.2 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.4 | 1.2 | GO:1905065 | regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.4 | 0.4 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.4 | 1.5 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.4 | 0.8 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.4 | 0.4 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
0.4 | 0.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.4 | 0.7 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.4 | 1.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.4 | 1.1 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.4 | 3.3 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.4 | 1.5 | GO:0061055 | myotome development(GO:0061055) |
0.4 | 0.4 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.4 | 1.1 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.4 | 0.7 | GO:0007418 | ventral midline development(GO:0007418) |
0.4 | 1.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 1.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.4 | 2.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 9.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.4 | 4.2 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.4 | 0.7 | GO:0002432 | granuloma formation(GO:0002432) |
0.3 | 1.0 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.3 | 0.3 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) |
0.3 | 0.7 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.3 | 1.7 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.3 | 1.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.3 | 1.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 0.3 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.3 | 1.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.3 | 2.0 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 1.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 0.7 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 0.7 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.3 | 0.3 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.3 | 1.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 1.0 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 1.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 1.0 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.3 | 1.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.3 | 2.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.3 | 0.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 3.2 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.3 | 0.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.3 | 0.6 | GO:0002254 | kinin cascade(GO:0002254) |
0.3 | 0.6 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 0.6 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.3 | 3.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.3 | 3.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 1.6 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.3 | 0.9 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.3 | 0.6 | GO:0050904 | diapedesis(GO:0050904) |
0.3 | 0.9 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.3 | 0.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.3 | 1.6 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.3 | 2.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 1.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 0.3 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.3 | 0.9 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 | 2.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.3 | 3.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 1.5 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.3 | 0.9 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.3 | 0.9 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.3 | 0.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.3 | 1.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.3 | 2.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 1.2 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.3 | 0.9 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 0.6 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.3 | 0.9 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 1.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.3 | 0.9 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.3 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 2.0 | GO:0015825 | L-serine transport(GO:0015825) |
0.3 | 0.6 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.3 | 0.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.3 | 0.9 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 0.6 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.3 | 0.8 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.3 | 1.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 0.3 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.3 | 7.1 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.3 | 2.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 0.6 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.3 | 1.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 4.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 | 0.6 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 1.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 0.6 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.3 | 0.8 | GO:0098901 | regulation of cardiac muscle cell action potential(GO:0098901) |
0.3 | 0.8 | GO:0042701 | progesterone secretion(GO:0042701) |
0.3 | 2.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.5 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.3 | 0.3 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.3 | 0.3 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.3 | 1.9 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.3 | 2.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 2.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.3 | 1.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.3 | 0.8 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.3 | 1.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 1.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.3 | 1.1 | GO:0070627 | ferrous iron import(GO:0070627) |
0.3 | 0.3 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.3 | 0.8 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.3 | 0.8 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 0.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.3 | 0.5 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.3 | 4.9 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.3 | 1.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 1.3 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.3 | 0.8 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.3 | 1.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.3 | 0.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 0.5 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 0.8 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.3 | 0.5 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 0.8 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.3 | 0.3 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.3 | 0.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.7 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 0.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 0.2 | GO:0003163 | sinoatrial node development(GO:0003163) |
0.2 | 0.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 1.0 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.2 | 0.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 1.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 0.7 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.2 | 0.7 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 0.7 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.2 | 1.0 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 0.7 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.2 | 0.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.2 | 0.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.7 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.2 | 0.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 0.5 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.2 | 1.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 0.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.2 | 0.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 1.4 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.2 | 5.9 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.2 | 0.7 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 0.5 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 1.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.2 | 0.9 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.2 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.2 | 2.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 0.9 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.2 | 2.8 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.2 | 0.2 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.2 | 0.2 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 0.9 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 0.9 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.2 | 0.5 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.2 | 0.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 0.5 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 0.7 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 0.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.2 | 0.4 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.2 | 0.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 2.0 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 1.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 1.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 1.6 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.2 | 0.2 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.2 | 0.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.9 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 1.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 0.2 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.2 | 3.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 0.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.7 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.2 | 0.9 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 0.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 0.4 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 0.9 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 0.6 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.2 | 0.4 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 0.8 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.2 | 0.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 0.8 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.8 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.2 | 2.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.6 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 1.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 0.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 | 1.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 0.8 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 1.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 1.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 2.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 1.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 0.8 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 0.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 2.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.2 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.2 | 0.8 | GO:0010755 | regulation of plasminogen activation(GO:0010755) positive regulation of plasminogen activation(GO:0010756) |
0.2 | 0.6 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.2 | 1.2 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 0.2 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.2 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 0.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.6 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.2 | 1.6 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.2 | 0.4 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 1.0 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 1.0 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.2 | 2.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 1.2 | GO:0097286 | iron ion import(GO:0097286) |
0.2 | 1.0 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.2 | 0.6 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.2 | 0.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.6 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 0.8 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.2 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 0.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 0.4 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.2 | 0.4 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.6 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 1.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 1.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.2 | 0.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 1.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.4 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.2 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 0.5 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 2.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 0.2 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
0.2 | 0.7 | GO:0046689 | response to mercury ion(GO:0046689) |
0.2 | 3.8 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 0.9 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.2 | 1.4 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.2 | 0.9 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 0.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 1.1 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.2 | 0.7 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.2 | 0.5 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.2 | 0.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 1.1 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.2 | 2.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 0.4 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 0.7 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 0.4 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.2 | 3.7 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.2 | 0.4 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.2 | 0.5 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 0.5 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 0.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 0.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 0.3 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.2 | 0.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 1.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 1.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 1.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 0.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 0.5 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.2 | 0.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.2 | 0.2 | GO:0032196 | transposition(GO:0032196) |
0.2 | 0.2 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.2 | 1.5 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.2 | 0.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 0.5 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.2 | 1.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.8 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.2 | 1.3 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 0.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.2 | 0.7 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 2.7 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 0.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.2 | 0.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 0.3 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 0.2 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 0.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 0.2 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.2 | 0.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 0.5 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 0.5 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 1.0 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.2 | 0.8 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.2 | 2.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.6 | GO:0003094 | glomerular filtration(GO:0003094) |
0.2 | 0.3 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.2 | 2.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.2 | 2.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 1.3 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.2 | 3.0 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 0.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.2 | 0.2 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.2 | 1.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 0.3 | GO:0003097 | renal water transport(GO:0003097) glycerol transport(GO:0015793) renal water absorption(GO:0070295) |
0.2 | 2.5 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.2 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.2 | 0.2 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.2 | 4.5 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.2 | 1.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 1.2 | GO:0010714 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.2 | 1.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 0.6 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.2 | 2.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 0.5 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.6 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 0.2 | GO:0002218 | activation of innate immune response(GO:0002218) |
0.2 | 0.6 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.2 | 0.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.2 | 0.9 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.2 | 0.3 | GO:0044838 | cell quiescence(GO:0044838) |
0.2 | 0.8 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.2 | 0.2 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.1 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.9 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 2.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 1.6 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.7 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.1 | 2.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 1.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.4 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.1 | GO:0036394 | amylase secretion(GO:0036394) |
0.1 | 0.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 0.1 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 1.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.1 | GO:0046102 | inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
0.1 | 1.0 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.1 | 0.4 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.4 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.1 | 0.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 1.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.3 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.1 | 0.3 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 1.0 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.1 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.1 | 0.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 1.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 4.1 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.1 | 1.5 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 1.9 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.5 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.1 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.1 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 1.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.7 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.1 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.4 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 1.2 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.1 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 1.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.7 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.7 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.8 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.4 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.1 | 0.3 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.1 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.1 | 0.7 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.4 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.3 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) potassium ion export across plasma membrane(GO:0097623) |
0.1 | 0.5 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.1 | 0.9 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.3 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.3 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.4 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 1.0 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.1 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.4 | GO:0032608 | interferon-beta production(GO:0032608) |
0.1 | 0.4 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.1 | 1.4 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.2 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.1 | 0.5 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 1.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.2 | GO:0061437 | renal system vasculature development(GO:0061437) kidney vasculature development(GO:0061440) |
0.1 | 0.1 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.1 | 0.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.2 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.8 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.1 | 0.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.2 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 2.0 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.1 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.2 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.1 | 0.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.1 | 1.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.1 | 0.5 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.1 | 0.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.9 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.3 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 1.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.9 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.7 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.2 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.1 | 0.5 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.3 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.1 | 1.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.2 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.1 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.2 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 0.3 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.1 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 0.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.6 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 2.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 1.0 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.9 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.1 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.1 | 0.9 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.2 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 1.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.5 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.1 | 0.3 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.3 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.2 | GO:0072604 | interleukin-6 secretion(GO:0072604) |
0.1 | 0.3 | GO:0046070 | dGTP catabolic process(GO:0006203) dGTP metabolic process(GO:0046070) |
0.1 | 0.2 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.1 | 0.2 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 0.8 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.8 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.2 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.1 | 0.2 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.1 | 1.0 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.3 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 3.1 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.3 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 0.5 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 0.6 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 1.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.6 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.6 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 1.3 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.9 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 0.3 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.1 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.1 | 0.3 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 1.2 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 2.5 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 5.1 | GO:0007599 | hemostasis(GO:0007599) |
0.1 | 0.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 1.8 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.1 | 0.5 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.2 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.1 | 1.2 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.1 | 0.3 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 1.0 | GO:0060713 | labyrinthine layer morphogenesis(GO:0060713) |
0.1 | 0.3 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 2.2 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 0.5 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.6 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 0.1 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.1 | 0.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.2 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 0.5 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.6 | GO:0042168 | heme metabolic process(GO:0042168) |
0.1 | 0.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.5 | GO:0032674 | regulation of interleukin-5 production(GO:0032674) |
0.1 | 0.6 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.2 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.1 | 0.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.3 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.1 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.1 | 0.4 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.4 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.8 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.5 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.4 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.8 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.1 | 1.7 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.1 | 0.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.4 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.1 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.1 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 1.2 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.3 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.3 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.3 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 8.2 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.1 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.2 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 1.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.6 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 1.6 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.2 | GO:0051029 | rRNA export from nucleus(GO:0006407) rRNA transport(GO:0051029) |
0.1 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.1 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.1 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.1 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.1 | 0.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.3 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.1 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.2 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.4 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
0.1 | 0.7 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.2 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.1 | 0.6 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 2.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.2 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.1 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.2 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.1 | 0.2 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.1 | GO:1902337 | regulation of apoptotic process involved in morphogenesis(GO:1902337) |
0.1 | 0.7 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.8 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.3 | GO:0050704 | regulation of interleukin-1 secretion(GO:0050704) regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.1 | 1.5 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.5 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.2 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.8 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.2 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.1 | GO:2000192 | negative regulation of fatty acid transport(GO:2000192) |
0.1 | 0.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.4 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 0.3 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.1 | GO:0010324 | membrane invagination(GO:0010324) |
0.1 | 0.1 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.7 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.4 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.1 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.2 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.6 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.2 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.3 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.1 | 0.1 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.1 | 0.3 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 0.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 1.0 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.3 | GO:0045078 | interferon-gamma biosynthetic process(GO:0042095) regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.1 | 0.1 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.1 | 0.6 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.2 | GO:0045851 | pH reduction(GO:0045851) |
0.1 | 0.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.5 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.3 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.1 | 0.1 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 1.2 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.1 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.5 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.1 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.1 | 0.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.3 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.1 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
0.1 | 0.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.1 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.1 | 0.1 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.1 | 0.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.2 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 0.5 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.3 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.5 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.2 | GO:0071047 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.1 | 0.1 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 1.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.1 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 0.1 | GO:0097178 | ruffle assembly(GO:0097178) |
0.1 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.4 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 1.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 2.2 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 0.2 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.1 | 0.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.2 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 0.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.1 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 1.6 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.1 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.1 | 4.4 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.2 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.1 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.1 | 0.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.2 | GO:0098763 | mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
0.1 | 0.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.1 | GO:0060129 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.1 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.1 | 0.2 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.2 | GO:1901679 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.1 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.2 | GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation(GO:2000516) |
0.1 | 0.9 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.2 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.2 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.1 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.1 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.1 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.0 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.0 | 0.2 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.0 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.0 | 0.0 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.1 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.0 | 0.0 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.0 | 0.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.2 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.1 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.0 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.4 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.8 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.0 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.0 | 0.0 | GO:0010042 | response to manganese ion(GO:0010042) response to cobalt ion(GO:0032025) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.0 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.6 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.1 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.7 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 0.2 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.0 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.1 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.0 | 0.2 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 0.1 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.0 | 0.0 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.1 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.0 | 0.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.2 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.2 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.1 | GO:0060045 | positive regulation of cardiac muscle cell proliferation(GO:0060045) |
0.0 | 0.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 1.8 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.5 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.5 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.0 | 0.1 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.5 | GO:0097352 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
0.0 | 0.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.0 | 0.0 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.0 | 0.5 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.6 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.0 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.0 | 1.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.0 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.2 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.8 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.0 | 0.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.0 | GO:0098801 | regulation of renal system process(GO:0098801) |
0.0 | 0.3 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.0 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.0 | 0.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.0 | 0.5 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.0 | 0.4 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.0 | 0.0 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.0 | 0.1 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.0 | GO:0003192 | mitral valve formation(GO:0003192) |
0.0 | 1.9 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.1 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.0 | 0.0 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.3 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.0 | 0.0 | GO:0070293 | renal absorption(GO:0070293) |
0.0 | 0.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.6 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.8 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.5 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.1 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.1 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) |
0.0 | 0.0 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
0.0 | 0.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.0 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.0 | 0.1 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.0 | 0.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.1 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.2 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.0 | 0.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.9 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.0 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.0 | 0.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.7 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.0 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.2 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.3 | GO:0071385 | cellular response to glucocorticoid stimulus(GO:0071385) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.1 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.1 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.5 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.1 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.2 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.0 | 0.3 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.1 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.1 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.4 | GO:0032963 | collagen metabolic process(GO:0032963) |
0.0 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.0 | 0.2 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.0 | 0.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.0 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.0 | 0.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.0 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.0 | 0.0 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.0 | 0.0 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.0 | 0.0 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.0 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.0 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 0.0 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.0 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.0 | 0.1 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 0.2 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.0 | GO:0071380 | cellular response to prostaglandin stimulus(GO:0071379) cellular response to prostaglandin E stimulus(GO:0071380) |
0.0 | 0.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.0 | 0.0 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.0 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.0 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.0 | 0.1 | GO:0051953 | negative regulation of amine transport(GO:0051953) |
0.0 | 0.0 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.0 | 0.1 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.0 | 0.2 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.0 | GO:0051031 | tRNA transport(GO:0051031) |
0.0 | 0.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.1 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.0 | GO:0060439 | trachea morphogenesis(GO:0060439) |
0.0 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.0 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.0 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.0 | 0.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.0 | 1.8 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.0 | GO:0015817 | histidine transport(GO:0015817) |
0.0 | 0.0 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.1 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.0 | 0.1 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.0 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 0.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.0 | 0.0 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 0.0 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.0 | 0.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.0 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.0 | 0.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 1.1 | GO:0071219 | cellular response to molecule of bacterial origin(GO:0071219) |
0.0 | 0.0 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.0 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.2 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.3 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.0 | 0.0 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.0 | 0.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.0 | 0.4 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.0 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.1 | GO:0019400 | glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
0.0 | 0.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.0 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.0 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 0.0 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.0 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 0.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.0 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.0 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.1 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.2 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.0 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.0 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.0 | 0.0 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.0 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.0 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.0 | 0.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.0 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.3 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.0 | 0.0 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.0 | GO:0008050 | female courtship behavior(GO:0008050) |
0.0 | 0.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 6.3 | GO:0030478 | actin cap(GO:0030478) |
1.1 | 17.2 | GO:0031430 | M band(GO:0031430) |
1.1 | 4.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.0 | 7.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.0 | 2.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.9 | 8.0 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.8 | 4.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.7 | 0.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.6 | 3.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.6 | 2.5 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.6 | 1.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.6 | 4.7 | GO:0005861 | troponin complex(GO:0005861) |
0.6 | 2.2 | GO:0008091 | spectrin(GO:0008091) |
0.6 | 2.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.5 | 4.9 | GO:0097542 | ciliary tip(GO:0097542) |
0.5 | 1.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.5 | 3.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 3.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 6.0 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 26.1 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.4 | 0.9 | GO:0044393 | microspike(GO:0044393) |
0.4 | 1.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 1.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.4 | 5.7 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.4 | 2.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 3.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 2.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.4 | 1.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.4 | 0.8 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.4 | 1.1 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.4 | 2.3 | GO:0097386 | glial cell projection(GO:0097386) |
0.4 | 2.5 | GO:0043219 | lateral loop(GO:0043219) |
0.3 | 1.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.3 | 2.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 5.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 5.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 0.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.3 | 1.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 2.9 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 2.5 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 0.9 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.3 | 1.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.3 | 1.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.3 | 0.3 | GO:1990423 | RZZ complex(GO:1990423) |
0.3 | 1.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 1.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 0.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.3 | 5.5 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.3 | 1.1 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 0.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 1.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 0.8 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.3 | 1.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 1.0 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.3 | 0.8 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 0.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 1.0 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 0.8 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 0.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 1.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 0.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 2.4 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 29.7 | GO:0030016 | myofibril(GO:0030016) |
0.2 | 2.6 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.7 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 1.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 3.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 2.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 0.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 1.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 0.7 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 2.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 5.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 0.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 6.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 1.4 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 1.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 1.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 4.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 2.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 2.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 0.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 0.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.2 | 2.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 0.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.2 | 0.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 0.8 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 1.7 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 1.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 0.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 2.2 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 1.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 1.0 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.6 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.2 | 1.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 39.9 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 0.5 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 9.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 0.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 0.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 0.6 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 2.4 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.7 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 1.1 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 1.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 7.5 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 1.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 2.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 1.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 6.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 3.0 | GO:0005912 | adherens junction(GO:0005912) |
0.1 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 2.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.5 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 1.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 4.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.7 | GO:0005818 | aster(GO:0005818) |
0.1 | 4.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 3.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 4.1 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 2.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.4 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.3 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 1.4 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.2 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 0.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.5 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 1.8 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 1.7 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.7 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.6 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.2 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 1.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 1.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.5 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.7 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.7 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 1.7 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 4.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.3 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.7 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 1.5 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.2 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 1.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.2 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 1.1 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.0 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.2 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 0.9 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.1 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 10.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.1 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 0.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 8.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 2.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.0 | GO:0042585 | germinal vesicle(GO:0042585) |
0.0 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.5 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.0 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 12.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.3 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.5 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.0 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 4.1 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 3.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 1.0 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 63.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.0 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 2.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.0 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.0 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.0 | GO:0098552 | side of membrane(GO:0098552) |
0.0 | 1.5 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 2.2 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.2 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 1.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.8 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 5.9 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.0 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.1 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.7 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 0.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.7 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.0 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.0 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.0 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 9.1 | GO:0031433 | telethonin binding(GO:0031433) |
1.8 | 5.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.3 | 5.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.3 | 3.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.2 | 3.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
1.2 | 3.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.1 | 3.4 | GO:0030172 | troponin C binding(GO:0030172) |
1.0 | 3.1 | GO:0035877 | death effector domain binding(GO:0035877) |
1.0 | 4.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.0 | 5.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.0 | 3.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.9 | 3.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.9 | 6.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.8 | 3.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.8 | 2.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.8 | 2.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.8 | 2.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.8 | 2.3 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.7 | 2.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.7 | 1.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.7 | 4.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.7 | 2.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.7 | 2.0 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.7 | 7.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.7 | 18.9 | GO:0042805 | actinin binding(GO:0042805) |
0.6 | 7.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.6 | 1.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.6 | 1.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.6 | 3.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.6 | 2.4 | GO:0071253 | connexin binding(GO:0071253) |
0.6 | 3.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.6 | 2.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.6 | 1.7 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.6 | 1.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 1.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.6 | 0.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.6 | 2.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.6 | 2.8 | GO:0017040 | ceramidase activity(GO:0017040) |
0.6 | 3.9 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.5 | 2.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.5 | 3.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.5 | 2.1 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.5 | 1.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.5 | 1.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.5 | 4.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 2.4 | GO:0008430 | selenium binding(GO:0008430) |
0.5 | 1.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.5 | 7.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.5 | 1.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 1.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.5 | 6.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.5 | 1.9 | GO:0043515 | kinetochore binding(GO:0043515) |
0.5 | 1.9 | GO:0030984 | kininogen binding(GO:0030984) |
0.5 | 1.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.5 | 3.2 | GO:0031432 | titin binding(GO:0031432) |
0.5 | 4.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.4 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.4 | 1.8 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.4 | 1.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.4 | 1.7 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.4 | 2.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 0.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 1.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 2.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 4.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 3.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 4.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.4 | 1.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.4 | 1.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.4 | 0.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 2.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 2.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.4 | 4.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 1.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.4 | 3.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 1.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.4 | 3.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 1.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.4 | 1.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.4 | 0.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 1.8 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 1.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.4 | 3.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 1.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 0.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 1.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.4 | 2.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 1.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.3 | 2.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 1.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 1.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 2.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 2.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 1.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 3.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 0.7 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 1.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 0.7 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 10.8 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.3 | 1.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 4.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 1.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 1.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 6.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 4.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 0.9 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 1.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 4.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 5.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 1.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 4.9 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 1.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 0.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 0.9 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 0.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 2.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 0.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 3.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 1.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 1.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 1.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 1.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 2.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.3 | 1.1 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 1.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.3 | 0.8 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 1.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 0.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 1.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 0.8 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.3 | 2.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 2.4 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.3 | 0.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 1.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 2.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.3 | 0.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 1.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 1.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 1.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 0.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 0.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 1.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 2.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 2.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 1.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.7 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.2 | 0.7 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 0.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 1.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.7 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.2 | 3.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 2.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.7 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 2.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 0.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 0.9 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 4.7 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 3.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 1.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 3.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 1.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.7 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.2 | 0.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 4.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 1.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.4 | GO:0048030 | disaccharide binding(GO:0048030) |
0.2 | 0.6 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 2.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 0.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 0.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.6 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.2 | 1.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 0.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 5.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 1.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 6.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 0.6 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.2 | 1.0 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.2 | 0.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 3.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 1.7 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 1.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 0.4 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.2 | 1.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 1.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 0.6 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 0.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 2.3 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 3.0 | GO:0052713 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.2 | 1.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 1.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 5.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 0.5 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 0.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 1.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 0.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 2.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.3 | GO:0090409 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 0.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 2.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 0.7 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 0.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 1.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 1.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 0.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.5 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.2 | 0.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 1.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 0.5 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.4 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 3.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 1.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.4 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 0.4 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 1.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.0 | GO:0018639 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.9 | GO:0043786 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 1.7 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.8 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 1.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.4 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 6.5 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 6.5 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.3 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.8 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.8 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 1.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 1.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 3.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 1.4 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 2.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 1.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 1.4 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 0.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.2 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.1 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 2.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 1.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.7 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.1 | 0.4 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 3.2 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 1.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 3.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 1.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 4.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 3.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.3 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 1.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 1.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 1.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.3 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.2 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.4 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.5 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 1.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.6 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 1.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.3 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.8 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.1 | 3.5 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 1.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 1.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 1.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.9 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 1.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 0.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 1.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.4 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.1 | 1.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 1.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.9 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.8 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 1.0 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.4 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 2.9 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.9 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 1.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.3 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 20.7 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 1.9 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 1.8 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 1.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.2 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.6 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.2 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 3.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.8 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 2.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.2 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.1 | 0.4 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 14.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 1.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 1.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.2 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 1.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 1.4 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 0.4 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 1.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 1.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 1.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 1.7 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.4 | GO:0019840 | isoprenoid binding(GO:0019840) |
0.1 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 1.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 3.3 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.7 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 1.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 4.5 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 5.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 1.7 | GO:0018731 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) retinyl-palmitate esterase activity(GO:0050253) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.2 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 2.3 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 1.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.0 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.1 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.0 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 3.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 1.2 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.0 | 0.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.0 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.0 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.0 | 2.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.0 | 0.1 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 1.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.4 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.2 | GO:0034944 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.0 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.0 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.0 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.1 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.2 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.2 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 4.5 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.9 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.3 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.3 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.2 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.0 | 0.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 2.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.2 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.2 | GO:0070990 | snRNP binding(GO:0070990) |
0.0 | 0.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.0 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.0 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.0 | 3.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.7 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.4 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.0 | GO:0060090 | binding, bridging(GO:0060090) |
0.0 | 0.0 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.0 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.0 | 0.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 2.2 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.0 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.4 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 1.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.5 | 4.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 0.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.5 | 3.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.4 | 21.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 3.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 15.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 3.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 10.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 1.6 | ST STAT3 PATHWAY | STAT3 Pathway |
0.4 | 0.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 1.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 3.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 6.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.4 | 6.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 2.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 5.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.3 | 2.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 0.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 4.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 11.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 3.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 4.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 2.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 12.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 7.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 4.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 11.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 1.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 12.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 0.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 4.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 3.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 9.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 1.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 0.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 4.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 4.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 3.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 0.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 2.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 3.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 0.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 4.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 7.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 4.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 0.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 1.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 3.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 7.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 4.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 2.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 6.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 4.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 2.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 4.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 1.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 1.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 2.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 5.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 0.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 4.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 1.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 0.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 0.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 5.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 2.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 4.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 4.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 4.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 2.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 2.0 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.7 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 2.4 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 13.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.3 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.6 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 6.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 1.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 3.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 8.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 2.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.7 | 6.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.7 | 0.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.6 | 6.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.6 | 13.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.5 | 5.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 24.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 11.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.4 | 4.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 3.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 4.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 8.3 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.3 | 3.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.3 | 5.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 2.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 7.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 4.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 3.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.3 | 4.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 4.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 1.7 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 2.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.3 | 3.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 0.5 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.3 | 2.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 28.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 4.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 2.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 5.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 2.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.3 | 8.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 2.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 4.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 5.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 1.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 2.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 2.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 5.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 4.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 1.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 3.9 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 6.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 2.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 2.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 3.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 4.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 2.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 1.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 1.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.2 | 2.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 6.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 1.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 2.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 2.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 2.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 2.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 1.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 1.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 2.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 0.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 0.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 4.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 3.9 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 0.7 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.2 | 0.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 1.7 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.2 | 6.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 0.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 1.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 10.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 0.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.3 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 0.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 1.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 6.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 1.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.1 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 4.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.2 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 1.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 2.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 8.5 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.1 | 1.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 7.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 5.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.1 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 3.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.4 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 0.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 1.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 0.6 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 2.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.5 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 1.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 0.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 1.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 3.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.5 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.0 | 5.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.8 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 1.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 2.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 1.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 1.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.5 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.6 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.3 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.1 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.3 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |